Cargando…

Acute effect of sacral neuromodulation for treatment of detrusor overactivity on urodynamic parameters

AIM: The aim of this study is to evaluate the acute effects of sacral neuromodulation (SNM) on various urodynamic parameters. METHODS: Patients with overactive bladder and detrusor overactivity (DO) who were planned for percutaneous nerve evaluation (PNE) were included. Directly after the PNE, a uro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Groenendijk, Ilse M., Groen, Jan, Scheepe, Jeroen R., Blok, Bertil F. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Clinical Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028062/ https://www.ncbi.nlm.nih.gov/pubmed/31804759 http://dx.doi.org/10.1002/nau.24252

Ejemplares similares

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

Urodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and/or low compliance bladder
por: Kaga, Kanya, et al.
Publicado: (2020)

Transcutaneous Electrical Stimulation of the Abdomen, Ear, and Tibial Nerve Modulates Bladder Contraction in a Rat Detrusor Overactivity Model: A Pilot Study
por: Coolen, Rosa L., et al.
Publicado: (2023)

Two‐year safety and efficacy outcomes for the treatment of overactive bladder using a long‐lived rechargeable sacral neuromodulation system
por: Blok, Bertil, et al.
Publicado: (2020)

Patient treatment preferences for symptomatic refractory urodynamic idiopathic detrusor overactivity
por: Fontaine, Christina L., et al.
Publicado: (2017)

A systematic review and activation likelihood estimation meta-analysis of the central innervation of the lower urinary tract: Pelvic floor motor control and micturition
por: Groenendijk, Ilse M., et al.
Publicado: (2021)

Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements
por: Javan Balegh Marand, Aida, et al.
Publicado: (2023)

The value of urodynamic tools to guide patient selection in sacral neuromodulation
por: Drossaerts, Jamie, et al.
Publicado: (2015)

Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin
por: Tijnagel, Marloes J., et al.
Publicado: (2017)

Effects of Acute Sacral Neuromodulation at Different Frequencies on Bladder Overactivity in Pigs
por: Li, Xing, et al.
Publicado: (2017)

OAB score: A clinical model that predicts the probability of presenting overactive detrusor in the urodynamic study
por: Arribillaga, Leandro Cristian, et al.
Publicado: (2018)

Effects of Acute Sacral Neuromodulation at Different Pulse Widths on Bladder Overactivity in Pigs
por: Cong, Huiling, et al.
Publicado: (2019)

Sacral neuromodulation in overactive bladder: a review and current perspectives
por: Sukhu, Troy, et al.
Publicado: (2016)

Coexisting overactive–underactive bladder and detrusor overactivity–underactivity in pelvic organ prolapse
por: Frigerio, Matteo, et al.
Publicado: (2022)

OnabotulinumtoxinA for the treatment of neurogenic detrusor overactivity in children
por: Austin, Paul F., et al.
Publicado: (2020)

Conditional neuromodulation of neurogenic detrusor overactivity using transrectal stimulation in patients with spinal cord injury: A proof of principle study
por: Knight, Sarah Louise, et al.
Publicado: (2017)

Whole brain 7T‐fMRI during pelvic floor muscle contraction in male subjects
por: Groenendijk, Ilse M., et al.
Publicado: (2019)

Sacral neuromodulation for overactive bladder using the InterStim and BetterStim systems
por: Meng, Lingfeng, et al.
Publicado: (2022)

Sleep disturbance changes in women after treatment of refractory overactive bladder with sacral neuromodulation
por: Sanderson, Derrick J., et al.
Publicado: (2020)

Investigating Urine Biomarkers in Detrusor Underactivity and Detrusor Overactivity with Detrusor Underactivity Patients
por: Jiang, Yuan-Hong, et al.
Publicado: (2023)

Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation
por: Trinh, Hamilton, et al.
Publicado: (2019)

A comparison of normal and high post-void residual urine and urodynamic parameters in women with overactive bladder
por: Dağdeviren, Hediye, et al.
Publicado: (2017)

Urodynamic Effects of Propiverine on Detrusor Overactivity and Abdominal Straining during Voiding in Awake Rats with Intravesical Prostaglandin E(2) Instillation
por: Oh, Jun Hyung, et al.
Publicado: (2010)

Urodynamic characteristics of detrusor underactivity in women with voiding dysfunction
por: Yang, Tsai-Hwa, et al.
Publicado: (2018)

Outcome and complications of adjustable continence therapy (ProACT(TM)) in the treatment of urinary incontinence after transurethral resection of the prostate: A multicenter study
por: Noordhoff, Toscane C., et al.
Publicado: (2019)

Automated quantification of low amplitude rhythmic contractions (LARC) during real-world urodynamics identifies a potential detrusor overactivity subgroup
por: Cullingsworth, Zachary E., et al.
Publicado: (2018)

Efficacy, according to urodynamics, of OnabotulinumtoxinA compared with antimuscarinic drugs, for neurogenic detrusor overactivity: a systematic review and network meta-analysis
por: Xu, Rui, et al.
Publicado: (2022)

Botulinum Toxin in Neurogenic Detrusor Overactivity
por: D'Ancona, Carlos Arturo Levi, et al.
Publicado: (2012)

Do Failure of Posterior Tibial Nerve Stimulation Precludes to Use Sacral Neuromodulation in Patient With Overactive Bladder?
por: Berthelot, Louis-Paul, et al.
Publicado: (2019)

Variable frequency stimulation of sacral neuromodulation in black-zone overactive bladder patients: a case report
por: Meng, Lingfeng, et al.
Publicado: (2020)

Axonics Sacral Neuromodulation System for Treating Refractory Overactive Bladder: A NICE Medical Technologies Guidance
por: Poole, Ruth Louise, et al.
Publicado: (2021)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
por: Tannenbaum, Stacey, et al.
Publicado: (2020)

Blebbistatin reveals beneficial effects on the cystometric parameters in an animal model of detrusor overactivity
por: Wróbel, Andrzej, et al.
Publicado: (2019)

Role of detrusor PDGFRα(+) cells in mouse model of cyclophosphamide-induced detrusor overactivity
por: Lee, Haeyeong, et al.
Publicado: (2022)

Two‐year outcomes of the ARTISAN‐SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system
por: Pezzella, Andrea, et al.
Publicado: (2021)

Alterations of the Myovesical Plexus of the Human Overactive Detrusor
por: Kuijpers, Kamiel A. J., et al.
Publicado: (2014)

Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis
por: Wu, Shang-Jun, et al.
Publicado: (2019)

Sexual dimorphism of detrusor function demonstrated by urodynamic studies in rhesus macaques
por: Biscola, Natalia P., et al.
Publicado: (2020)

Detrusor underactivity versus bladder outlet obstruction clinical and urodynamic factors
por: Kalil, Jefferson, et al.
Publicado: (2020)

Urodynamic effectiveness of a beta-3 adrenoreceptor agonist (vibegron) for a pediatric patient with anticholinergic-resistant neurogenic detrusor overactivity: a case report
por: Kato, Taiki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gu4tkq3i1abu2q2ani31a65i1q